To present a corporate overview

Cornerstone Therapeutics Inc. announced that it has appointed Andrew K. W. Powell, Esq. Executive Vice President, General Counsel and Secretary. In this role, Mr. Powell will join the Company's executive management team and manage its legal function and corporate governance processes. He will report to Craig Collard, Cornerstone's President and Chief Executive Officer. Mr. Powell brings 20 years of corporate legal leadership in the life sciences industry. Most recently, he served as Senior Vice President, General Counsel, Secretary, at ImClone Systems Inc.

Cornerstone Therapeutics Inc. reported unaudited consolidated financial results for the third quarter and nine months ended September 30, 2009. Third quarter net revenues increased $2.5 million to $23.1 million, or 12%, compared to the third quarter of 2008. Non-GAAP income from operations for the third quarter was $2.8 million against $6.6 million a year ago. GAAP loss from operations was $1.04 million against income of $6.4 million a year ago. GAAP net loss was $538,000 or $0.03 loss per diluted share against net income of $3.3 million or $0.48 per diluted share a year ago. Non-GAAP net income was $1.48 million or $0.07 per diluted share against net income of $3.4 million or $0.49 per diluted share a year ago. Loss before income taxes was $1.04 million against income before income tax of $6.05 million a year ago. Net revenues for the nine months ended September 30, 2009 increased $34.7 million over the same period in 2008, or 79%, to $78.8 million. GAAP income from operations was $12.4 million against income of $10.8 million a year ago. Non-GAAP income from operations for the third quarter was $19.7 million against $11.98 million a year ago. GAAP net income was $7.5 million or $0.46 per diluted share against net income of $6.1 million or $0.89 per diluted share a year ago. Non-GAAP net income was $11.94 million or $0.74 per diluted share against net income of $6.9 million or $1.00 per diluted share a year ago. Income before income taxes was $12.29 million against income before income tax of $9.7 million a year ago. Net cash used in operating activities was $8.99 million against net cash provided by operating activities of $9.8 million a year ago. Purchase of property and equipment was $250,000 against $24,000 a year ago. Based on expected contributions from Curosurf and Factive in the fourth quarter, Cornerstone is increasing its revenue guidance from in excess of $95 million to in excess of $104 million for the full-year 2009. In addition, the company anticipates achieving income from operations on a GAAP basis of $15 million and on a non-GAAP basis of $26.1 million.